Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides

Brad A. Hartl, David L. Boucher, Laura Marcu, Simon R Cherry

Research output: Chapter in Book/Report/Conference proceedingConference contribution


Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.

Original languageEnglish (US)
Title of host publicationOptical Trapping Applications, OTA 2013
StatePublished - 2013
EventOptical Trapping Applications, OTA 2013 - Waikoloa Beach, HI, United States
Duration: Apr 14 2013Apr 18 2013


OtherOptical Trapping Applications, OTA 2013
Country/TerritoryUnited States
CityWaikoloa Beach, HI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Atomic and Molecular Physics, and Optics


Dive into the research topics of 'Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides'. Together they form a unique fingerprint.

Cite this